Europe
GENFIT announced Dr. Dean Hum’s appointment as President of GENFIT Corp. and Dr. Suneil Hosmane as Head of Global Diagnostics.
SphingoTec GmbH announced that novel data on its sphingotest penKid assay for Proenkephalin, a unique and proprietary biomarker for real-time assessment of kidney function, will be presented at the 32nd Annual Congress of the European Society of Intensive Care Medicine taking place in Berlin on September 28 to October 2, 2019.
Special Projects Laboratory opened in EKF’s Cardiff HQ to develop new applications in non-core markets and support other global diagnostics R&D facilities
Helsinn announces an abstract has been accepted for oral presentation at the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Meeting 2019 taking place from September 26-28, 2019 in Athens, Greece.
Adrenomed AG, the vascular integrity company, announced the successful completion of patient enrollment in the proof-of-concept Phase II trial, AdrenOSS-2, evaluating Adrecizumab in patients with early septic shock.
T3 Pharmaceuticals AG, a Basel-based company focusing on immuno-oncology, closes its second financing round of over 12M CHF with existing investors joined by Boehringer Ingelheim Venture Fund and Reference Capital SA.
Appointment widens industry leadership perspective, translational and commercial expertise
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014.
MedinCell’s CEO Christophe Douat states: “We are happy to report that the mdc-CWM program, partnered and in phase 2 clinical trial, is progressing well and on schedule.”
Menarini Silicon Biosystems will host a symposium on the importance of liquid biopsy and circulating tumor cells (CTCs) in advancing precision medicine for patients with metastatic breast and prostate cancer.
PRESS RELEASES